Dafna Capital Management LLC Pro Qr Therapeutics N.V. Transaction History

Dafna Capital Management LLC

$389 Million
Q3 2024

A detailed history of Dafna Capital Management LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Dafna Capital Management LLC holds 905,582 shares of PRQR stock, worth $2.32 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

905,582

Previous 905,582 -0.0%

Holding current value

$2.32 Million

Previous $1.5 Million 9.65%

% of portfolio

0.42%

Previous 0.39%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.89 - $2.85 $66,150 - $99,750	-35,000 Reduced 3.72%	905,582 $2.07 Million
Q1 2023 May 15, 2023	BUY	$1.99 - $3.66 $1.87 Million - $3.44 Million	940,582 New	940,582 $2 Million
Q3 2022 Nov 14, 2022	BUY	$0.74 - $0.89 $480,543 - $577,950	649,383 New	649,383 $483,000
Q1 2022 May 16, 2022	SELL	$0.9 - $8.39 $76,928 - $717,143	-85,476 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.58 - $8.44 $1.39 Million - $1.78 Million	-210,907 Reduced 71.16%	85,476 $685,000
Q3 2021 Nov 15, 2021	SELL	$5.16 - $8.47 $3.8 Million - $6.23 Million	-735,497 Reduced 71.28%	296,383 $2.48 Million
Q2 2021 Aug 16, 2021	SELL	$5.75 - $7.59 $391,690 - $517,030	-68,120 Reduced 6.19%	1,031,880 $6.96 Million
Q1 2021 May 17, 2021	SELL	$4.14 - $9.22 $568,836 - $1.27 Million	-137,400 Reduced 11.1%	1,100,000 $7.27 Million
Q1 2020 May 15, 2020	BUY	$5.25 - $9.9 $647,850 - $1.22 Million	123,400 Added 11.08%	1,237,400 $6.79 Million
Q4 2019 Feb 14, 2020	BUY	$5.84 - $10.51 $4.98 Million - $8.96 Million	852,479 Added 325.97%	1,114,000 $11 Million
Q1 2019 May 15, 2019	SELL	$12.5 - $18.48 $136,912 - $202,411	-10,953 Reduced 4.02%	261,521 $3.63 Million
Q4 2018 Feb 14, 2019	BUY	$15.25 - $22.4 $185,104 - $271,891	12,138 Added 4.66%	272,474 $4.3 Million
Q3 2018 Nov 14, 2018	BUY	$6.45 - $21.6 $573,953 - $1.92 Million	88,985 Added 51.93%	260,336 $5.04 Million
Q2 2018 Aug 13, 2018	SELL	$2.95 - $7.45 $175,286 - $442,671	-59,419 Reduced 25.75%	171,351 $1.25 Million
Q4 2017 Feb 14, 2018	BUY	$2.8 - $4.8 $646,156 - $1.11 Million	230,770	230,770 $744,000

Others Institutions Holding PRQR

# of Institutions

Shares Held

17.4M

Call Options Held

37.7K

Put Options Held

21.3K

View Full List

About ProQR Therapeutics N.V.

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $183M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

More about PRQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Pro Qr Therapeutics N.V. Transaction History